Ling Bi
725 South Wanping Rd
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Yifeixiaoji decoction as an adjunct to osimertinib therapy in advanced EGFR-mutated NSCLC: protocol for a randomized, double-blind, placebo-controlled trial.
Journal: Frontiers in medicine
Published: May 25, 2026
An FAK Kinase/Scaffold Mode-Switch in Dormancy and Resistance.
Journal: Cancers
Published: February 23, 2026
Adjuvant Chemotherapy with Traditional Chinese Herbal Granules Versus Placebo in Resected Non-Small Cell Lung Cancer: Updated Survival Analysis of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
Journal: Integrative cancer therapies
Published: January 27, 2026
Ruanjian Sanjie Formula Affects Metastasis of Lung Cancer by Regulating miR-182-5p/EPAS1/EMT Axis.
Journal: Chinese journal of integrative medicine
Published: January 26, 2026
Liquid-Liquid Phase Separation in Cancer Drug Resistance: Mechanisms and Therapeutic Opportunities.
Journal: Oncology research
Published: November 21, 2025
Thlaspi arvense attenuates colitis-associated colorectal tumorigenesis through suppression of neutrophil recruitment via the NOD/NF-κB pathway.
Journal: Chinese medicine
Published: November 21, 2025
Association of peripheral inflammatory cell counts with depression among cancer survivors: a cross-sectional study based on the NHANES dataset.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: March 04, 2025
Thlaspi arvense suppresses gut microbiota related TNF inflammatory pathway to alleviates ulcerative colitis.
Journal: Frontiers in immunology
Published: November 30, 2024
Inhibition of Dormant Lung Cancer Cell Reactivation by Punica Granatum Peel and Dioscorea Nipponica: Involving MYC, SKP2 and p27.
Journal: Drug design, development and therapy
Published: October 25, 2024
Clinical Efficacy and Gut Microbiota Regulating-Related Effect of Si-Jun-Zi Decoction in Postoperative Non-Small Cell Lung Cancer Patients: A Prospective Observational Study.
Journal: Integrative cancer therapies
Published: March 20, 2024
A phosphoglycerate mutase 1 allosteric inhibitor restrains TAM-mediated colon cancer progression.
Journal: Acta pharmaceutica Sinica. B
Published: March 17, 2024
Last Updated: 09/26/2026